micronutri.ai is BioFund's AI-guided bioactive discovery and enhancement platform — built to identify, optimize, and transform natural compounds into high-performance ingredients across nutrition, health, and prevention.
Getting a natural compound to actually work in the body — at meaningful levels, with consistent bioavailability, across formulations — is where most bioactive programmes fail. The active compounds are often there. The absorption is not.
micronutri.ai was built around that problem. Two integrated capabilities: AI-guided discovery to identify and optimize bioactive candidates from natural sources, and the UFP500 platform to dramatically enhance their bioavailability through ultra-fine particle processing — preserving what makes them valuable while making them genuinely usable.
AI-assisted identification and rational optimization of bioactive compounds from natural sources — targeting inflammation reduction, immune support, and microbiome balance. Computational screening eliminates the guesswork from candidate selection, generating high-confidence targets before a single formulation is attempted.
The UFP500 platform transforms natural bioactive compounds through ultra-fine particle processing — reducing particle size to 1–5 microns under controlled, low-heat conditions. This approach preserves heat-sensitive compounds, dramatically improves bioavailability, and enables cleaner, more effective formulations across food, health, and cosmetic applications.
From validated bioactive to finished formulation — across food, functional nutrition, nutraceuticals, cosmetics, and agriculture. Co-development programmes are built around the partner's application context, with shelf-stability, sensory profile, and regulatory pathway considered from day one.
Prevention science that connects compound bioactivity to measurable health outcomes. micronutri.ai works within BioFund's OneHealth translational framework — validating prevention applications across both animal and human health, building the evidence base that takes natural ingredients from promising to proven.
A compound with remarkable bioactivity is worthless if the body cannot absorb it. UFP500 processing begins with this premise — and every programme on the platform is built around it.
Low-heat, controlled processing protects what conventional milling destroys — the heat-sensitive enzymes, volatile actives, and delicate compounds that give natural ingredients their value. The processing serves the compound, not the other way around.
Every programme is built with a prevention outcome in mind — measurable, specific, and connected to the broader understanding of how chronic inflammation, immune dysregulation, and metabolic imbalance precede disease.
micronutri.ai was built because we faced these problems ourselves.
Finding the right natural compounds for a specific health outcome. Getting them to actually absorb and perform in a real formulation. Transforming an agricultural byproduct or undervalued natural material into something with genuine bioactive value. Building a prevention programme that is grounded in science, not marketing.
We respond only where there is genuine scientific alignment.